This study provides an experimental foundation that will contribute to future insights into the role of CCK8 modulation in the intestinal IgA response with clinical impact on chronic dysfunctions such as inflammatory bowel diseases [26]. This evidence concerns the gene CD79A and inflammatory bowel disease.